Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001104659-18-036488

Chairman & CEO acquired 135,889 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Patel Sanj K · Chairman & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2018-05-29 Conversion : show line 1 in the form +135,889 245,685 D

Table II: Derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2018-02-09 Purchase : show line 2 in the form Series C Preferred Shares +63,922 $15.64 $999,983 63,922 D
2018-05-29 Conversion : show line 3 in the form Series A Preferred Shares −428,203 0 D
2018-05-29 Conversion : show line 4 in the form Series B Preferred Shares −71,967 0 D
2018-05-29 Conversion : show line 5 in the form Series C Preferred Shares −63,922 0 D
2018-05-29 Conversion : show line 6 in the form Class B Common Shares +428,203 1,526,160 D
Loading xslF345X03/a4.xml…